Commitments and Contingencies, Including License and Sponsored Research Agreements - Additional Information (Details) - USD ($)				1 Months Ended	3 Months Ended		6 Months Ended		22 Months Ended
	Jan. 01, 2025	Mar. 16, 2023	Oct. 06, 2020	Aug. 31, 2022	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024	May 04, 2023
Minimum
Commitments And Contingencies [Line Items]
Percentage of royalties owed on sublicense income				10.00%
Maximum
Commitments And Contingencies [Line Items]
Percentage of royalties owed on sublicense income				20.00%
DRL Agreement
Commitments And Contingencies [Line Items]
Aggregate regulatory milestone payments									$ 200,000
License agreement upfront fee		$ 400,000
Pre-approval regulatory milestone payments		2,900,000
Additional payments of other development and sales milestones		$ 20,000,000
ARScience License Agreement
Commitments And Contingencies [Line Items]
Developmental milestones				$ 5,900,000
ARScience License Agreement | First Combination Product
Commitments And Contingencies [Line Items]
Developmental milestones				13,300,000
ARScience License Agreement | Combination Product
Commitments And Contingencies [Line Items]
Developmental milestones				11,600,000
ARScience License Agreement | First Mono Product
Commitments And Contingencies [Line Items]
Developmental milestones				11,800,000
ARScience License Agreement | Mono Product
Commitments And Contingencies [Line Items]
Developmental milestones				$ 5,900,000
Methodist License
Commitments And Contingencies [Line Items]
License termination condition description.							The Methodist License Agreement provides that in the event the Company sublicense products and services covered by the Methodist License Agreement, then royalties owed to Houston Methodist would be computed as a percentage of payments received by the Company from the sublicensee. In addition, the termination provisions provide that Houston Methodist may terminate the Methodist License Agreement, among other things, in the event that after five years the Company is not “Actively Attempting to Develop or Commercialize,” as such term is defined in the Methodist License Agreement.
Maximum aggregate amount payable upon milestone achievement of specific development and regulatory events.			$ 400,000
Minimum annual amount owned upon commercialization	$ 100,000
Methodist research fund										$ 500,000
Sponsored Research Agreement
Commitments And Contingencies [Line Items]
Minimum Total Funding							$ 1,000,000
Maximum Total Funding							1,200,000
Total fund							1,000,000
Research and development expenses					$ 300,000	$ 100,000	$ 500,000	$ 200,000